Literature DB >> 20934570

Racial differences in long-term survival among patients with coronary artery disease.

Kevin L Thomas1, Emily Honeycutt, Linda K Shaw, Eric D Peterson.   

Abstract

BACKGROUND: Cardiovascular disease is the leading cause of death among blacks and whites in the United States. Despite this, there are insufficient data on the long-term prognosis of black patients with coronary artery disease (CAD) as well as the major clinical related determinants of outcome.
METHODS: We studied 22,618 patients (3,314 black) having significant CAD findings at cardiac catheterization performed at Duke from January 1986 to December 2004 with follow-up through June 2006. Using Kaplan-Meier and Cox modeling, we compared unadjusted and adjusted long-term survival by patient race and gender (median follow-up 7.6 years, interquartile range 3.5-13.0) as well as identified major patient characteristics associated with survival.
RESULTS: Blacks with CAD were younger; were more often female; had lower median household incomes; and had more hypertension, diabetes mellitus, and heart failure. The number of coronary vessels with significant disease was similar by race. At 15-year follow-up, black women had the lowest survival and white men had the highest (41.5% vs 45.8%, P < .0001). Blacks were less likely to receive initial therapy with coronary revascularization (odds ratio 0.66, 95% CI 0.60-0.72, P < .0001). After adjusting for baseline clinical and demographic characteristics and initial treatment selection, black race remained an independent predictor of lower survival (hazard ratio 2.54, 95% CI 1.60-4.04, P < .0001).
CONCLUSIONS: Among patients with CAD, blacks have lower long-term survival compared with whites. The difference may be partially, but not fully, explained by differences in cardiovascular risk factors and 30-day revascularization rates.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934570     DOI: 10.1016/j.ahj.2010.06.014

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  32 in total

1.  Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis.

Authors:  Benjamin E Tourdot; Stanley Conaway; Katrin Niisuke; Leonard C Edelstein; Paul F Bray; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

2.  Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.

Authors:  Leonard C Edelstein; Lukas M Simon; Cory R Lindsay; Xianguo Kong; Raúl Teruel-Montoya; Benjamin E Tourdot; Edward S Chen; Lin Ma; Shaun Coughlin; Marvin Nieman; Michael Holinstat; Chad A Shaw; Paul F Bray
Journal:  Blood       Date:  2014-10-07       Impact factor: 22.113

3.  The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans.

Authors:  Joshua J Joseph; Xiaofei Zhou; Mihail Zilbermint; Constantine A Stratakis; Fabio R Faucz; Maya B Lodish; Annabel Berthon; James G Wilson; Willa A Hsueh; Sherita H Golden; Shili Lin
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

4.  Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial Disparity.

Authors:  Jimmy T Efird; Andy C Kiser; Patricia B Crane; Hope Landrine; Linda C Kindell; Margaret-Ann Nelson; Charulata Jindal; Daniel F Sarpong; William F Griffin; T Bruce Ferguson; W Randolph Chitwood; Stephen W Davies; Alan P Kypson; Preeti Gudimella; Ethan J Anderson
Journal:  Pharmacotherapy       Date:  2017-02-03       Impact factor: 4.705

5.  Race differences in platelet reactivity: is protease activated receptor 4 a predictor of response to therapy?

Authors:  Michele M Mumaw; Marvin T Nieman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12       Impact factor: 8.311

6.  Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease.

Authors:  Heidi Mochari-Greenberger; Ming Liao; Lori Mosca
Journal:  Am J Cardiol       Date:  2013-11-07       Impact factor: 2.778

Review 7.  Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.

Authors:  Joonseok Kim; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

8.  Relationship of Coronary Calcium on Standard Chest CT Scans With Mortality.

Authors:  Jan M Hughes-Austin; Arturo Dominguez; Matthew A Allison; Christina L Wassel; Dena E Rifkin; Cindy G Morgan; Michael R Daniels; Umaira Ikram; Jessica B Knox; C Michael Wright; Michael H Criqui; Joachim H Ix
Journal:  JACC Cardiovasc Imaging       Date:  2016-01-06

9.  Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study.

Authors:  Norman C Wang; Karen A Matthews; Emma J M Barinas-Mitchell; Chung-Chou H Chang; Samar R El Khoudary
Journal:  Menopause       Date:  2016-06       Impact factor: 2.953

Review 10.  Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies.

Authors:  Jie Ding; Hui Xu; Xiang Yin; Fu-rong Zhang; Xiao-ping Pan; Yi-an Gu; Jun-zhu Chen; Xiao-gang Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.